We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Leica Microsystems' US Acquisition Expands Histopathology Range

By Labmedica staff writers
Posted on 19 May 2008
Print article
In a move that further advances its strong global position in the histopathology field, Leica Microsystems announced the acquisition of the assets of US-based Coretech Holdings. The acquired concern is to become a business unit within Leica Microsystems' Biosystems Division, and will be renamed Leica Biosystems St. Louis, LLC. Terms of the transaction were not disclosed.

Composed of a group of strong brands including McCormick Scientific, The Vibratome Company, Paraplast embedding media, TurbOflow II histology cassettes and myNeuroLab.com, Coretech (St. Louis, MO, USA) provides an extensive range of systems, instruments, reagents, and consumables for the clinical and research histology laboratory.

According to Doug Martin, formerly CEO of Coretech Holdings and now Vice President & General Manager of Leica Biosystems St. Louis, LLC, The synergies created by combining the Coretech products and team with those of Leica Microsystems are considerable. Both companies will quickly leverage an improved product offering for our customers and expand our ability to service their needs.

Anne De Greef-Safft, President of Leica Microsystems' Biosystems Division added, With this acquisition, Leica Microsystems continues to broaden and strengthen the product line we offer our customers. The benefit to customers is that they now have a single partner to come to for all their histology equipment, reagent, and consumable needs. Having internal R&D, as well as manufacturing capabilities for the instrument and their associated reagents and consumables allows us to better optimize the entire system, leading to higher quality and more consistent results for our customers.

Leica Microsystems (Wetzlar, Germany) is a leading global developer and producer of precision optical systems for the analysis of microstructures. The company manufactures a broad range of products requiring microscopic imaging, measurement, and analysis, and offers system solutions for life sciences including biotechnology and medicine, R&D of raw materials, and industrial quality assurance. Leica Microsystems is represented in over 100 countries with 9 manufacturing facilities in 7 countries, sales and service organizations in 19 countries and an international network of dealers.


Related Links:
Coretech
Leica Microsystems
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
17 Beta-Estradiol Assay
17 Beta-Estradiol Assay
New
Gold Member
Syphilis Screening Test
VDRL Antigen MR

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.